Trials / Completed
CompletedNCT00000442
Naltrexone for Relapse Prevention
Etiology and Treatment of Alcohol Dependence
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 57 (planned)
- Sponsor
- UConn Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the safety and effectiveness of an injectable slow releasing preparation of naltrexone to reduce alcohol consumption and risk of relapse in alcohol-dependent subjects. Individuals will receive either naltrexone or a placebo injection for a total of three months, with two subsequent followup visits spanning a 6- month period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | naltrexone (Revia) |
Timeline
- Completion
- 2002-12-01
- First posted
- 1999-11-03
- Last updated
- 2011-06-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000442. Inclusion in this directory is not an endorsement.